Track cost pressure
Identify presentations with rising spend and create intervention plans focused on switching opportunities or formulary alignment.
BNF presentation directory
Explore British National Formulary presentations, drill into dispensing trend data, and identify which pharmacies drive the greatest usage of each medicine.
| Presentation | Product | Chemical substance | Chapter | Items dispensed |
|---|---|---|---|---|
|
Episenta 500mg modified-release granules sachets
0408010W0BIADBS
|
Episenta | Sodium valproate | Central Nervous System | 1,496 |
|
Stalevo 75mg/18.75mg/200mg tablets
0409010X0BBAEAE
|
Stalevo | Levodopa/carbidopa/entacapone | Central Nervous System | 1,491 |
|
Moclobemide 150mg tablets
0403020K0AAAAAA
|
Moclobemide | Moclobemide | Central Nervous System | 1,482 |
|
Seroquel 25mg tablets
0402010ABBBABAB
|
Seroquel | Quetiapine | Central Nervous System | 1,482 |
|
Zomig 5mg/0.1ml nasal spray 0.1ml unit dose
0407041Z0BBACAC
|
Zomig | Zolmitriptan | Central Nervous System | 1,477 |
|
Vigabatrin 500mg tablets
0408010X0AAAAAA
|
Vigabatrin | Vigabatrin | Central Nervous System | 1,476 |
|
Cipramil 20mg tablets
0403030D0BBAAAA
|
Cipramil hydrobromide | Citalopram hydrobromide | Central Nervous System | 1,462 |
|
Maxalt 10mg tablets
0407041R0BBABAB
|
Maxalt | Rizatriptan | Central Nervous System | 1,460 |
|
Topamax 200mg tablets
040801050BBACAC
|
Topamax | Topiramate | Central Nervous System | 1,448 |
|
Diazepam 5mg/2.5ml rectal solution tube
0401020K0AAADAD
|
Diazepam | Diazepam | Central Nervous System | 1,446 |
|
Olanzapine 15mg orodispersible tablets
040201060AAAYAY
|
Olanzapine | Olanzapine | Central Nervous System | 1,445 |
|
Pramipexole 1.57mg modified-release tablets
0409010W0AAAJAJ
|
Pramipexole | Pramipexole | Central Nervous System | 1,437 |
|
Sastravi 125mg/31.25mg/200mg tablets
0409010X0BCAAAF
|
Sastravi | Levodopa/carbidopa/entacapone | Central Nervous System | 1,434 |
|
Xenidate XL 27mg tablets
0404000M0BIAEAT
|
Xenidate | Methylphenidate hydrochloride | Central Nervous System | 1,432 |
|
Tolfenamic acid 200mg tablets
0407041U0AAABAB
|
Tolfenamic acid | Tolfenamic acid | Central Nervous System | 1,407 |
|
Codeine 25mg/5ml oral solution
0407020C0AAABAB
|
Codeine phosphate (Analgesic) | Codeine phosphate | Central Nervous System | 1,402 |
|
Longtec 120mg modified-release tablets
0407020ADBEAFAP
|
Longtec | Oxycodone hydrochloride | Central Nervous System | 1,387 |
|
Phenelzine 15mg tablets
0403020M0AAAAAA
|
Phenelzine sulfate | Phenelzine sulfate | Central Nervous System | 1,386 |
|
Contulen 50mg tablets
0403030Q0BCAAAA
|
Contulen | Sertraline hydrochloride | Central Nervous System | 1,385 |
|
Venlablue XL 37.5mg capsules
0403040W0BRACAS
|
Venlablue | Venlafaxine | Central Nervous System | 1,378 |
|
Fluanxol 1mg tablets
0403040F0BBABAB
|
Fluanxol | Flupentixol hydrochloride | Central Nervous System | 1,375 |
|
Zimovane LS 3.75mg tablets
0401010Z0BBABAC
|
Zimovane | Zopiclone | Central Nervous System | 1,372 |
|
Sumatriptan 3mg/0.5ml inj pre-filled disposable devices
0407041T0AAAJAJ
|
Sumatriptan | Sumatriptan succinate | Central Nervous System | 1,369 |
|
Oxycodone 60mg modified-release tablets
0407020ADAAAQAQ
|
Oxycodone hydrochloride | Oxycodone hydrochloride | Central Nervous System | 1,365 |
|
Tranylcypromine 10mg tablets
0403020Q0AAAAAA
|
Tranylcypromine sulfate | Tranylcypromine sulfate | Central Nervous System | 1,364 |
Why monitor BNF codes?
Link medicine usage to pharmacy and prescriber behaviour to find optimisation opportunities.
Understand demand drivers
Cross-reference high-volume medicines with local health priorities and prescriber activity to target support programs.